ATE137801T1 - Gegen hiv 1 gp48 spezifische antikörper - Google Patents

Gegen hiv 1 gp48 spezifische antikörper

Info

Publication number
ATE137801T1
ATE137801T1 AT89908105T AT89908105T ATE137801T1 AT E137801 T1 ATE137801 T1 AT E137801T1 AT 89908105 T AT89908105 T AT 89908105T AT 89908105 T AT89908105 T AT 89908105T AT E137801 T1 ATE137801 T1 AT E137801T1
Authority
AT
Austria
Prior art keywords
specific antibodies
against hiv
kda
hiv
lymphocytes
Prior art date
Application number
AT89908105T
Other languages
English (en)
Inventor
Kurt B Osther
Original Assignee
Verigen Inc A Corp Of Delaware
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Verigen Inc A Corp Of Delaware filed Critical Verigen Inc A Corp Of Delaware
Application granted granted Critical
Publication of ATE137801T1 publication Critical patent/ATE137801T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1145—Env proteins, e.g. gp41, gp110/120, gp160, V3, principal neutralising domain [PND] or CD4-binding site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4216—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-viral Ig
    • C07K16/4225—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-viral Ig against anti-HIV Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • AIDS & HIV (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT89908105T 1988-07-06 1989-07-06 Gegen hiv 1 gp48 spezifische antikörper ATE137801T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21586788A 1988-07-06 1988-07-06

Publications (1)

Publication Number Publication Date
ATE137801T1 true ATE137801T1 (de) 1996-05-15

Family

ID=22804732

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89908105T ATE137801T1 (de) 1988-07-06 1989-07-06 Gegen hiv 1 gp48 spezifische antikörper

Country Status (5)

Country Link
EP (1) EP0423198B1 (de)
JP (1) JPH03505668A (de)
AT (1) ATE137801T1 (de)
DE (1) DE68926454T2 (de)
WO (1) WO1990000617A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06508133A (ja) * 1991-05-31 1994-09-14 ジェネンテク，インコーポレイテッド Ｈｉｖに関連した免疫性の血小板減少性紫斑病の治療
NZ252161A (en) * 1992-05-22 1996-10-28 Sandoz Ltd Monoclonal murine internal image anti-idiotypic antibodies (ab2) to monoclonal antibodies br55 (ab1), their production and use in immunizing against hiv and epithelial and lung cancers

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2780020B2 (ja) * 1983-04-27 1998-07-23 プレジデント アンド フェロウズ オブ ハーバード カレッジ ヒトｔ細胞白血病ウイルス抗原及び該抗原を用いる検出方法
US4722888A (en) * 1985-03-29 1988-02-02 United States Of America As Represented By The Department Of Health And Human Services Cell line producing human monoclonal antibody which binds to HTLV-I producing cells

Also Published As

Publication number Publication date
DE68926454T2 (de) 1997-01-09
WO1990000617A1 (en) 1990-01-25
EP0423198B1 (de) 1996-05-08
JPH03505668A (ja) 1991-12-12
DE68926454D1 (de) 1996-06-13
EP0423198A1 (de) 1991-04-24

Similar Documents

Publication Publication Date Title
DE69435126D1 (de) Synthetische humane neutralisierende monoklonale antikörper gegen hiv
EP0345462A3 (de) Immuntest für HIV-1-Antigene unter Benutzung von F(AB')2-Fragmenten als Sonde
ES2113854T3 (es) Derivados de albumina con funciones terapeuticas.
DE3853779D1 (de) Hiv-1 neutralisierende monoklonale antikörper.
EP0675904A4 (de) Humane neutralisierende monoklonale antikörper gegen den die immunschwäche auslösenden virus aus mensch.
NO970221L (no) Humane nöytraliserende monoklonale antistoffer mot humant immunsviktvirus
ES2067866T3 (es) Reactivos inmunologicos que reaccionan con un epitopo constante del virus inmunodeficiente humano del tipo i (vih-1)gp120 y metodos de utilizacion.
DK2267452T3 (da) Opløseligt kompleks omfattende et retroviralt overfladeglycoprotein
TR200001553T2 (tr) HIV-1 Tat veya bunun türevleri.
FI882173A7 (fi) Synteettinen peptidiantigeeni HIV-2-tartunnan toteamiseksi.
RU94045826A (ru) Моноклональные антитела против рецептора интерферона, с нейтрализующим действием против интерферона типа i
NO881151D0 (no) Syntetisk hiv-1-antigen.
FI935217A0 (fi) Basisk dissocieringsanalys
CA2004478A1 (en) Monoclonal antibodies to feline-t-lymphotropic lentivirus
FR2731013B1 (fr) Vih-1 de groupe o, fragments desdits virus, ainsi que leurs applications
FI891957A7 (fi) HIV-env-koodattuja peptidejä, jotka aikaansaavat HIV-inhiboivien vasta-aineiden muodostuksen nisäkkäissä
CA2192512A1 (en) Nm03 antibody materials and methods
FI923099L (fi) Biomassa foer att producera virus/ virusantigen.
DE69128108D1 (de) Monoklonaler Antikörper gegen HTLV-III (Stamm MN)
DE68926454D1 (de) Gegen hiv 1 gp48 spezifische antikörper
ITVR940096A0 (it) Procedimento ed apparecchiatura per l'immunoadsorbimento specifico di virus hiv, di antigene gp120 e complesso cd4-gp120.
KR890700683A (ko) 인체 면역 결핍 바이러스에 대한 항체 검색 방법
DK1438970T3 (da) Fremgangsmåde til at inhibere HIV-associerede sygdomme ved hjælp af monoklonale antistoffer rettet mod sig-selv-rettede cytotoksiske celler
ATE128733T1 (de) Monoklonale antikörper gegen hiv gp120.
FI924576A7 (fi) CTAA 28A32, MCA 28A32:n tunnistama antigeeni

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee